학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

First-in-man phase I, open-label, dose-escalating clinical and pharmacokinetic study of the novel antimicrotubulin agent PM060184 administered over 10 minutes on days 1, 8, and 15 every four weeks to patients with advanced malignant solid tumours

Document Type

Journal

Author

Delord, J. P.; Elez, E.; Gomez Roca, C.; Coronado, C.; Lignon, N.; Martinez de Arenzana, L.; Fudio, S.; De Miguel Lillo, B.; Matos Pita, A. Soto; Tabernero, J.

Source

EUROPEAN JOURNAL OF CANCER; SEP 2013, 49 pS188-pS188, 1p. Supplement: 2

Subject

Language

English

ISSN

18790852

Online Access

Full Text (ScienceDirect) Full Text (Clinical Key) Web of Science JCR 저널정보 Find it@PNU

이메일